• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Enforcement Report - Week of January 3, 2024

    FDA

    Enforcement Report - Week of November 8, 2023

    FDA

    Enforcement Report - Week of February 1, 2023

    FDA

    Enforcement Report - Week Of June 01, 2022

    FDA

    Enforcement Report - Week of July 8, 2020

    FDA

    Enforcement Report - Week of June 24, 2020

    FDA

    GSK Consumer Healthcare Issues Voluntary Nationwide Recall of Children`s Robitussin®

    FDA

    Enforcement Report - Week of May 20, 2020

    FDA

    Enforcement Report - Week of April 1, 2020

    FDA

    Enforcement Report - Week of October 2, 2019

    FDA

    Enforcement Report - Week of October 17, 2018

    FDA

    Enforcement Report - Week of July 12, 2017

    FDA

    Enforcement Report - Week of May 31, 2017

    FDA

    GlaxoSmithKline, LLC Receives Voluntarily Recalls Of Ventolin HFA (albuterol sulfate)

    FDA

    FDA Issues Form 483 to Marksans Pharma Ltd.

    FDA

    Enforcement Report - Week of April 12, 2017

    FDA

    Enforcement Report - Week of April 5, 2017

    FDA

    GlaxoSmithKline`s Buckley Syrups Has Initiated A Voluntary Recall

    HEALTH CANADA

    Glaxo Wellcome UK Ltd Recalls 4 Batches Of Respontin Due to Out of Specification Results for Impurities Obtained During Routine Stability Testing

    MHRA

    SmithKline Beecham Limited Receives FDA Warning Letter

    FDA

    GSK recalls Ventolin HFA Inhalation Aerosol due to Defective Delivery System

    FDA

    Glaxosmithkline (Tianjin) Company Ltd. Fails EDQM Inspection

    EUDRA GMP

    GlaxoSmithKline recalls Bactroban (mupirocin calcium) Nasal Ointment, 2% due to Cross Contamination

    FDA

    Recalls of products made at GlaxoSmithkline due to presence of Foreign Substance

    FDA

    Labeling Foul-Up Involving Acetaminophen Leads RB to Recall 135 Lots of Mucinex

    FIERCE PHARMA MANUFACTURING

    Chinese Square Off Against Alibaba in Palace Intrigue as Online Drug Sales Loom

    FIERCE PHARMA

    German Drugmakers Appeal Drug Suspensions Linked to Indian Data

    REUTERS

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.